Quick Answer
Nuvation Bio Inc. reported Stockholders Equity of $305.72 million for fiscal year 2025.
Nuvation Bio Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $305.72M | -34.1% |
| 2024 | $463.79M | -23.4% |
| 2023 | $605.12M | -7.6% |
| 2022 | $655.08M | -12.2% |
| 2021 | $746.00M | +246.8% |
| 2020 | $215.08M | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $117.75M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $325.88M | -35.2% | -12.6% |
| June 30, 2025 | $372.91M | +45.0% | -11.1% |
| March 31, 2025 | $419.46M | -29.4% | -9.6% |
| December 31, 2024 | $463.79M | -23.4% | -7.7% |
| September 30, 2024 | $502.71M | -17.8% | +95.5% |
| June 30, 2024 | $257.19M | -58.8% | -56.7% |
| March 31, 2024 | $594.04M | -7.3% | -1.8% |
| December 31, 2023 | $605.12M | -7.6% | -1.1% |
- Nuvation Bio Inc. showed a decrease of -34.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Nuvation Bio Inc.’s stockholders equity has grown by 159.6% (from $117.75 million to $305.72 million).
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: